Network
Network
The EMIG Network includes approximately 1,500 individuals from Member companies and organisations, ranging from pharma companies to Associate Members offering vital services. Our membership also extends to patient charities, research organisations, and universities, all of which benefit from free membership.
Members can access collective expertise through our 'Network Questions' service. This allows any member to anonymously submit a question or request assistance via our web portal, with responses made freely available in the members' area.
I'm looking for recommendations for organisations that support companies with tender responses
We are looking for a warehouse company where we can stock and distribute stock and samples for our field team
I’m seeking peer input on MHRA’s interpretation of the “Contract Giver” requirement in Part C of the QP Declaration following the April 2025 EMA Q&A update (EMA/129980/2025)
How are companies processing their TOV / Disclosure data?
Has anyone with an Irish MAH been able to sell into Ireland without having a WDA?
Can EMIG members recommend any good third party companies to work with in relation to the extended producer responsibility (EPR) regulations.
Can EMIG members recommend a third party company who offer a UK plastic offsetting service offering?
We are seeking to recruit a Responsible Person (RP) and a Responsible Person Import (RPI).
Can anyone recommend someone to help secure UKCA certification from MHRA?
Our global organisation is concerned about the potential for UK confidential net prices to become known to the Trump administration
We received a response from the DHSC advising they located a comparator product, however it is a separate generic with similar indications.
We have decided to go with a Reduced wholesale model (RWA) across two wholesalers and are trying to avoid the 'OOS' or 'not available' messages at AAH due to them not being part of the RWA.
Absence of UK data in phase III clinical trials for NICE submission
I am looking for solutions that can real time track patient initiations or retrospectively estimate initiations on our medicine.
Could anyone advise the best approach to take to engage with NICE for them to reassess a previously negative NICE TA outcome for a product.
We are looking for any companies/individuals with experience in selling weightloss medicines into the private market
Looking to compare typical contact rates across UK and larger European countries.
Does anyone have experience of interim funding from draft NICE guidance via the IMF? Any advice on what we need to consider to support rapid uptake?
Pseudonymised patient-level data from UK homecare providers to support commercial analytics through a third-party provider. How to approach GDPR compliance e.g. patient consent required etc?
Commercial asceptic compounder
Seeking and agency that manages accounts receivable with experience managing healthcare organisations/ NHS debt collection.
Can any members recommend a cheap formulary tracking service/tool for a small start-up Pharma business.
Shipments to Guernsey, Jersey and Isle of Man
Does anyone know any independent UK HTA consultants who could help strategically advise and review a European company putting a dossier together for NICE and SMC?
Can somebody help to advise on where I could source some short term business analyst support for a project?